Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeted therapy for malignant melanoma

I R Hart1, R G Vile

  • 1Richard Dimbleby Department of Cancer Research, St. Thomas' Hospital, London, UK.

Current Opinion in Oncology
|March 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer.

Gene therapy·2016
Same author

Dermal and conjunctival melanocytic proliferations in diffuse uveal melanocytic proliferation.

Eye (London, England)·2013
Same author

Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in (V600D/E)BRAF mutant melanoma depends on JNK and TNF-α signaling.

Oncogene·2013
Same author

Oncolytic Vaccinia virus and radiotherapy in head and neck cancer.

Oral oncology·2012
Same author

Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin-paclitaxel doublet chemotherapy.

Gene therapy·2012
Same author

Dynamics of melanoma tumor therapy with vesicular stomatitis virus: explaining the variability in outcomes using mathematical modeling.

Gene therapy·2011

Targeted melanoma therapies can leverage the pigment biosynthesis pathway. Researchers used gene regulatory elements to specifically deliver therapeutic genes to melanoma cells, aiming for reduced side effects.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Malignant melanoma presents unique therapeutic opportunities due to its pigment biosynthesis pathway.
  • Targeted therapy approaches can exploit this pathway for selective treatment delivery.

Purpose of the Study:

  • To investigate the use of 5'-flanking sequences of pigment synthesis genes for targeted gene expression in melanoma.
  • To explore the potential of driving expression of therapeutic genes specifically within melanoma cells.

Main Methods:

  • Utilized 5'-flanking sequences of tyrosinase and tyrosinase-related protein 1 genes.
  • Engineered these sequences to drive the expression of complementary DNA (cDNA).
  • The cDNA encoded for immunity-stimulating proteins or drug-activating enzymes.

Related Experiment Videos

Main Results:

  • Demonstrated tissue-specific gene expression driven by melanoma-associated gene regulatory elements.
  • Successfully targeted the expression of therapeutic genes to melanoma cells.

Conclusions:

  • Melanoma-specific gene regulation offers a strategy for targeted therapy.
  • Combining tissue specificity with novel delivery systems can enhance therapeutic index and minimize side effects.